Trial Profile
RTA 402 Phase 3 Clinical Trial (A Randomized, Double-blind, Placebo-controlled Clinical Trial in Patients with Diabetic Kidney Disease)
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 14 Feb 2024
Price :
$35
*
At a glance
- Drugs Bardoxolone methyl (Primary)
- Indications Diabetic neuropathies
- Focus Registrational; Therapeutic Use
- Sponsors Kyowa Kirin
- 07 Feb 2024 Status changed from recruiting to discontinued, according to a Kyowa Kirin media release.
- 07 Feb 2024 According to a Kyowa Kirin media release, company decided to discontinue the drug RTS-402 in nephrology field.
- 11 May 2018 Status changed from planning to recruiting.